Status:

WITHDRAWN

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

Massachusetts General Hospital

Beth Israel Deaconess Medical Center

Conditions:

End Stage Renal Disease

Hemodialysis

Eligibility:

All Genders

18-85 years

Phase:

PHASE4

Brief Summary

Cardiovascular disease is the primary cause of death in patients with end stage renal disease (ESRD). New research suggests that the high risk of death may be partly due to high levels of fibrosis and...

Detailed Description

We hypothesize that that abnormalities in aldosterone and nitric oxide (NO) homeostasis contribute to the progression of microvascular disease and myocardial fibrosis in ESRD and that agents designed ...

Eligibility Criteria

Inclusion

  • Chronic dialysis therapy for End Stage Renal Disease
  • Age 21-85

Exclusion

  • Hyperkalemia requiring unscheduled dialysis within 3 months
  • Pre-dialysis potassium ≥6.5 meq/L within 3 months
  • Hypotension defined as SBP \<100
  • Recurrent intra-dialytic hypotension defined as recurrent cramping, light-headedness, or hypotension requiring infusion of saline or other intervention or otherwise limiting ability to achieve dry weight. Or SBP \<80
  • History of myocardial infarction
  • History of coronary artery bypass surgery
  • Non revascularized coronary disease \>90%
  • Mitral valve repair or replacement
  • Severe mitral valve disease
  • Renal transplant expected within 9 months
  • Expected survival \< 9 months
  • Pregnant
  • Prisoners
  • Unable to provide consent
  • Allergy to spironolactone or L-arginine
  • Digitalis use
  • 1st or 2nd degree heart block

Key Trial Info

Start Date :

September 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01855334

Start Date

September 1 2013

End Date

July 1 2018

Last Update

May 4 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 021114

2

Brigham & Women's Hospital

Boston, Massachusetts, United States, 02120

3

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD | DecenTrialz